Deepak K Sarpal1, Delbert G Robinson2, Todd Lencz2, Miklos Argyelan1, Toshikazu Ikuta3, Katherine Karlsgodt4, Juan A Gallego2, John M Kane2, Philip R Szeszko2, Anil K Malhotra2. 1. Department of Psychiatry, Zucker Hillside Hospital, North Shore-LIJ Health System, Glen Oaks, New York. 2. Department of Psychiatry, Zucker Hillside Hospital, North Shore-LIJ Health System, Glen Oaks, New York2Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, New York3Department of Psychiatry, Hofstra North Shore-Long Is. 3. School of Applied Sciences, Department of Communication Sciences and Disorders, University of Mississippi, University. 4. Department of Psychiatry, Zucker Hillside Hospital, North Shore-LIJ Health System, Glen Oaks, New York2Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, New York.
Abstract
IMPORTANCE: Previous evidence has implicated corticostriatal abnormalities in the pathophysiology of psychosis. Although the striatum is the primary target of all efficacious antipsychotics, the relationship between its functional connectivity and symptomatic reduction remains unknown. OBJECTIVE: To explore the longitudinal effect of treatment with second-generation antipsychotics on functional connectivity of the striatum during the resting state in patients experiencing a first episode of psychosis. DESIGN, SETTING, AND PARTICIPANTS: This prospective controlled study took place at a clinical research center and included 24 patients with first-episode psychosis and 24 healthy participants matched for age, sex, education, and handedness. Medications were administered in a double-blind randomized manner. INTERVENTIONS: Patients were scanned at baseline and after 12 weeks of treatment with either risperidone or aripiprazole. Their symptoms were evaluated with the Brief Psychiatric Rating Scale at baseline and follow-up. Healthy participants were scanned twice within a 12-week interval. MAIN OUTCOMES AND MEASURES: Functional connectivity of striatal regions was examined via functional magnetic resonance imaging using a seed-based approach. Changes in functional connectivity of these seeds were compared with reductions in ratings of psychotic symptoms. RESULTS:Patients had a median exposure of 1 day to antipsychotic medication prior to being scanned (mean [SD] = 4.5 [6.1]). Eleven patients were treated witharipiprazole and 13 patients were treated with risperidone. As psychosis improved, we observed an increase in functional connectivity between striatal seed regions and the anterior cingulate, dorsolateral prefrontal cortex, and limbic regions such as the hippocampus and anterior insula (P < .05, corrected for multiple comparisons). Conversely, a negative relationship was observed between reduction in psychosis and functional connectivity of striatal regions with structures within the parietal lobe (P < .05, corrected for multiple comparisons). CONCLUSIONS AND RELEVANCE: Our results indicated that corticostriatal functional dysconnectivity in psychosis is a state-dependent phenomenon. Increased functional connectivity of the striatum with prefrontal and limbic regions may be a biomarker for improvement in symptoms associated with antipsychotic treatment.
RCT Entities:
IMPORTANCE: Previous evidence has implicated corticostriatal abnormalities in the pathophysiology of psychosis. Although the striatum is the primary target of all efficacious antipsychotics, the relationship between its functional connectivity and symptomatic reduction remains unknown. OBJECTIVE: To explore the longitudinal effect of treatment with second-generation antipsychotics on functional connectivity of the striatum during the resting state in patients experiencing a first episode of psychosis. DESIGN, SETTING, AND PARTICIPANTS: This prospective controlled study took place at a clinical research center and included 24 patients with first-episode psychosis and 24 healthy participants matched for age, sex, education, and handedness. Medications were administered in a double-blind randomized manner. INTERVENTIONS:Patients were scanned at baseline and after 12 weeks of treatment with either risperidone or aripiprazole. Their symptoms were evaluated with the Brief Psychiatric Rating Scale at baseline and follow-up. Healthy participants were scanned twice within a 12-week interval. MAIN OUTCOMES AND MEASURES: Functional connectivity of striatal regions was examined via functional magnetic resonance imaging using a seed-based approach. Changes in functional connectivity of these seeds were compared with reductions in ratings of psychotic symptoms. RESULTS:Patients had a median exposure of 1 day to antipsychotic medication prior to being scanned (mean [SD] = 4.5 [6.1]). Eleven patients were treated with aripiprazole and 13 patients were treated with risperidone. As psychosis improved, we observed an increase in functional connectivity between striatal seed regions and the anterior cingulate, dorsolateral prefrontal cortex, and limbic regions such as the hippocampus and anterior insula (P < .05, corrected for multiple comparisons). Conversely, a negative relationship was observed between reduction in psychosis and functional connectivity of striatal regions with structures within the parietal lobe (P < .05, corrected for multiple comparisons). CONCLUSIONS AND RELEVANCE: Our results indicated that corticostriatal functional dysconnectivity in psychosis is a state-dependent phenomenon. Increased functional connectivity of the striatum with prefrontal and limbic regions may be a biomarker for improvement in symptoms associated with antipsychotic treatment.
Authors: Mark S Bolding; David M White; Jennifer A Hadley; Martin Weiler; Henry H Holcomb; Adrienne C Lahti Journal: Front Psychiatry Date: 2012-12-06 Impact factor: 5.435
Authors: Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey Journal: Neuropsychopharmacology Date: 2009-08-12 Impact factor: 7.853
Authors: Deepak K Sarpal; Miklos Argyelan; Delbert G Robinson; Philip R Szeszko; Katherine H Karlsgodt; Majnu John; Noah Weissman; Juan A Gallego; John M Kane; Todd Lencz; Anil K Malhotra Journal: Am J Psychiatry Date: 2015-08-28 Impact factor: 18.112
Authors: Rebecca E Watsky; Stephen J Gotts; Rebecca A Berman; Harrison M McAdams; Xueping Zhou; Dede Greenstein; Francois M Lalonde; Peter Gochman; Liv S Clasen; Lorie Shora; Anna E Ordóñez; Nitin Gogtay; Alex Martin; Deanna M Barch; Judith L Rapoport; Siyuan Liu Journal: Schizophr Res Date: 2018-01-06 Impact factor: 4.939
Authors: Jun Hua; Nicholas I S Blair; Adrian Paez; Ann Choe; Anita D Barber; Allison Brandt; Issel Anne L Lim; Feng Xu; Vidyulata Kamath; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis Journal: Schizophr Res Date: 2018-11-06 Impact factor: 4.939